Text Message Reminder-Recalls For Early Childhood Vaccination
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01199666 |
Recruitment Status
:
Completed
First Posted
: September 13, 2010
Last Update Posted
: July 25, 2014
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Vaccination | Other: Text message | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 2586 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Investigator) |
Primary Purpose: | Health Services Research |
Official Title: | Text 4 Health-Kids: Text Message Reminder-Recalls For Early Childhood Vaccination |
Study Start Date : | June 2011 |
Actual Primary Completion Date : | July 2013 |
Actual Study Completion Date : | July 2013 |
Arm | Intervention/treatment |
---|---|
Experimental: Text message reminders |
Other: Text message
text message appointment and immunization reminders
|
Active Comparator: standard of care for MMR, letter reminder for Hep A
MMR: automated phone call appointment reminder Hep A: recall letter, automated phone call appointment reminder
|
Other: Text message
text message appointment and immunization reminders
|
- Receipt of MMR1 [ Time Frame: by 13 and 16 months of age ]
- Timeliness of HepA vaccination post-recall [ Time Frame: 4,12, 24 weeks ]
- Attendance at appointments [ Time Frame: after appointment ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 9 Months to 50 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Parents of child >9 months to 25 months
- Child with at least one visit to one of the participating clinical sites in the previous 12 months
- Parental cell phone number recorded in the registration system

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01199666
United States, New York | |
Columbia University Medical Center | |
New York, New York, United States, 10032 |
Principal Investigator: | Melissa S Stockwell, MD MPH | Columbia University | |
Study Director: | Annika Hofstetter, MD PhD MPH | Columbia University |
Responsible Party: | Melissa Stockwell, MD, MPH, Asst Prof of Pediatrics and Population and Family Health, Columbia University |
ClinicalTrials.gov Identifier: | NCT01199666 History of Changes |
Other Study ID Numbers: |
AAAF4263 |
First Posted: | September 13, 2010 Key Record Dates |
Last Update Posted: | July 25, 2014 |
Last Verified: | July 2014 |
Keywords provided by Melissa Stockwell, MD, MPH, Columbia University:
Underimmunization, text message, vaccination Underimmunization |
Additional relevant MeSH terms:
Vaccines Immunologic Factors Physiological Effects of Drugs |